

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 5.58409478 |
| 2 | response to muscle activity (GO:0014850) | 4.97822969 |
| 3 | cardiac myofibril assembly (GO:0055003) | 4.72388383 |
| 4 | chondrocyte development (GO:0002063) | 4.55774535 |
| 5 | melanin biosynthetic process (GO:0042438) | 4.49722798 |
| 6 | muscle filament sliding (GO:0030049) | 4.46601794 |
| 7 | actin-myosin filament sliding (GO:0033275) | 4.46601794 |
| 8 | myotube cell development (GO:0014904) | 4.37653015 |
| 9 | plasma membrane repair (GO:0001778) | 4.37313259 |
| 10 | skeletal muscle fiber development (GO:0048741) | 4.23772743 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.18844937 |
| 12 | melanin metabolic process (GO:0006582) | 4.16348587 |
| 13 | collagen fibril organization (GO:0030199) | 4.13462783 |
| 14 | actin-mediated cell contraction (GO:0070252) | 4.10157758 |
| 15 | muscle cell cellular homeostasis (GO:0046716) | 4.04979045 |
| 16 | response to inactivity (GO:0014854) | 4.04025415 |
| 17 | myofibril assembly (GO:0030239) | 4.01081336 |
| 18 | muscle fiber development (GO:0048747) | 4.00136509 |
| 19 | * muscle system process (GO:0003012) | 3.96442706 |
| 20 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.68610198 |
| 21 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.63292841 |
| 22 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.62334879 |
| 23 | axon extension involved in axon guidance (GO:0048846) | 3.62334879 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.61266460 |
| 25 | negative regulation of protein localization to cell surface (GO:2000009) | 3.60531766 |
| 26 | skeletal muscle tissue development (GO:0007519) | 3.57931442 |
| 27 | secondary metabolite biosynthetic process (GO:0044550) | 3.53589114 |
| 28 | * relaxation of muscle (GO:0090075) | 3.52885059 |
| 29 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.51182536 |
| 30 | skeletal muscle adaptation (GO:0043501) | 3.48040605 |
| 31 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.46306387 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 3.45858498 |
| 33 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.41936879 |
| 34 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.40397514 |
| 35 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.40377392 |
| 36 | muscle cell fate commitment (GO:0042693) | 3.39933642 |
| 37 | sarcomere organization (GO:0045214) | 3.36682356 |
| 38 | striated muscle adaptation (GO:0014888) | 3.35902762 |
| 39 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.33629776 |
| 40 | actin filament-based movement (GO:0030048) | 3.33340701 |
| 41 | notochord development (GO:0030903) | 3.31389119 |
| 42 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.30630394 |
| 43 | muscle hypertrophy (GO:0014896) | 3.30425610 |
| 44 | striated muscle cell development (GO:0055002) | 3.29207785 |
| 45 | muscle structure development (GO:0061061) | 3.28712741 |
| 46 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.27585136 |
| 47 | muscle organ development (GO:0007517) | 3.27481533 |
| 48 | skeletal muscle tissue regeneration (GO:0043403) | 3.22496415 |
| 49 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.21338366 |
| 50 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.21338366 |
| 51 | positive regulation of vasculogenesis (GO:2001214) | 3.19439103 |
| 52 | regulation of cell communication by electrical coupling (GO:0010649) | 3.18822279 |
| 53 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.15594708 |
| 54 | cardiac muscle contraction (GO:0060048) | 3.10555296 |
| 55 | adult heart development (GO:0007512) | 3.07873558 |
| 56 | chondrocyte proliferation (GO:0035988) | 3.07117532 |
| 57 | regulation of myoblast differentiation (GO:0045661) | 3.06584698 |
| 58 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05542350 |
| 59 | paraxial mesoderm development (GO:0048339) | 3.05495470 |
| 60 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.05395317 |
| 61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.03239132 |
| 62 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.03051070 |
| 63 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.03051070 |
| 64 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.02473629 |
| 65 | cartilage condensation (GO:0001502) | 3.02162785 |
| 66 | cell aggregation (GO:0098743) | 3.02162785 |
| 67 | positive regulation of myoblast differentiation (GO:0045663) | 2.99211026 |
| 68 | cardiac muscle adaptation (GO:0014887) | 2.98385039 |
| 69 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.98385039 |
| 70 | muscle hypertrophy in response to stress (GO:0003299) | 2.98385039 |
| 71 | muscle cell development (GO:0055001) | 2.98026043 |
| 72 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.97963170 |
| 73 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.96534499 |
| 74 | actomyosin structure organization (GO:0031032) | 2.89700579 |
| 75 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.89275995 |
| 76 | regulation of actin filament-based movement (GO:1903115) | 2.86513591 |
| 77 | * regulation of muscle system process (GO:0090257) | 2.85466698 |
| 78 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.85303197 |
| 79 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.85303197 |
| 80 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.83533560 |
| 81 | relaxation of cardiac muscle (GO:0055119) | 2.82563294 |
| 82 | regulation of sarcomere organization (GO:0060297) | 2.81839728 |
| 83 | endocardial cushion development (GO:0003197) | 2.80809257 |
| 84 | regulation of skeletal muscle contraction (GO:0014819) | 2.80790339 |
| 85 | regulation of cardioblast differentiation (GO:0051890) | 2.80481773 |
| 86 | striated muscle atrophy (GO:0014891) | 2.78523933 |
| 87 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.78043356 |
| 88 | myoblast fusion (GO:0007520) | 2.76478673 |
| 89 | striated muscle contraction (GO:0006941) | 2.74990573 |
| 90 | muscle tissue development (GO:0060537) | 2.71505855 |
| 91 | cardiac muscle hypertrophy (GO:0003300) | 2.70934017 |
| 92 | striated muscle tissue development (GO:0014706) | 2.70124685 |
| 93 | cardiac muscle cell development (GO:0055013) | 2.69657117 |
| 94 | regulation of the force of heart contraction (GO:0002026) | 2.69335061 |
| 95 | response to caffeine (GO:0031000) | 2.69144008 |
| 96 | * regulation of muscle contraction (GO:0006937) | 2.68296471 |
| 97 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.66251186 |
| 98 | positive regulation of fibroblast migration (GO:0010763) | 2.65469560 |
| 99 | pericardium development (GO:0060039) | 2.64491723 |
| 100 | muscle tissue morphogenesis (GO:0060415) | 2.64465197 |
| 101 | nucleus localization (GO:0051647) | 2.63373968 |
| 102 | extracellular fibril organization (GO:0043206) | 2.63241609 |
| 103 | nerve growth factor signaling pathway (GO:0038180) | 2.62282770 |
| 104 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.61955496 |
| 105 | establishment of nucleus localization (GO:0040023) | 2.61794748 |
| 106 | regulation of vasculogenesis (GO:2001212) | 2.60613361 |
| 107 | regulation of axon guidance (GO:1902667) | 2.60403106 |
| 108 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.59617659 |
| 109 | negative regulation of hormone metabolic process (GO:0032351) | 2.59617659 |
| 110 | metanephric mesenchyme development (GO:0072075) | 2.58936614 |
| 111 | smooth muscle tissue development (GO:0048745) | 2.58562048 |
| 112 | keratan sulfate catabolic process (GO:0042340) | 2.57819046 |
| 113 | positive regulation of muscle hypertrophy (GO:0014742) | 2.56503083 |
| 114 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.56503083 |
| 115 | heart morphogenesis (GO:0003007) | 2.56420613 |
| 116 | striated muscle hypertrophy (GO:0014897) | 2.56050106 |
| 117 | regulation of membrane repolarization (GO:0060306) | 2.54885428 |
| 118 | muscle atrophy (GO:0014889) | 2.54876976 |
| 119 | muscle adaptation (GO:0043500) | 2.54692034 |
| 120 | cardiac cell development (GO:0055006) | 2.54473189 |
| 121 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.53997354 |
| 122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.52747689 |
| 123 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.52148584 |
| 124 | regulation of skeletal muscle fiber development (GO:0048742) | 2.51748880 |
| 125 | atrial septum morphogenesis (GO:0060413) | 2.51435535 |
| 126 | peripheral nervous system axon ensheathment (GO:0032292) | 2.50903403 |
| 127 | myelination in peripheral nervous system (GO:0022011) | 2.50903403 |
| 128 | creatine metabolic process (GO:0006600) | 2.50510242 |
| 129 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.50250055 |
| 130 | cellular response to dexamethasone stimulus (GO:0071549) | 2.49929985 |
| 131 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.49529468 |
| 132 | protein heterotrimerization (GO:0070208) | 2.48527338 |
| 133 | replacement ossification (GO:0036075) | 2.47179906 |
| 134 | endochondral ossification (GO:0001958) | 2.47179906 |
| 135 | bone trabecula formation (GO:0060346) | 2.46898970 |
| 136 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.46766051 |
| 137 | cartilage morphogenesis (GO:0060536) | 2.45557463 |
| 138 | endocardial cushion morphogenesis (GO:0003203) | 2.44308115 |
| 139 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43612325 |
| 140 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.41372824 |
| 141 | hippo signaling (GO:0035329) | 2.41297684 |
| 142 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.41191609 |
| 143 | glomerular filtration (GO:0003094) | 2.40809224 |
| 144 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.40551514 |
| 145 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.40019061 |
| 146 | axonal fasciculation (GO:0007413) | 2.38043115 |
| 147 | cell migration involved in heart development (GO:0060973) | 2.36858507 |
| 148 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.35926886 |
| 149 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.35516615 |
| 150 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.32226851 |
| 151 | regulation of striated muscle contraction (GO:0006942) | 2.31570293 |
| 152 | regulation of cardioblast proliferation (GO:0003264) | 2.31075320 |
| 153 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.31075320 |
| 154 | cartilage development (GO:0051216) | 2.30513763 |
| 155 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.29384731 |
| 156 | syncytium formation (GO:0006949) | 2.27933511 |
| 157 | muscle contraction (GO:0006936) | 2.27508603 |
| 158 | negative regulation of fatty acid transport (GO:2000192) | 2.26925008 |
| 159 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.26673763 |
| 160 | kidney mesenchyme development (GO:0072074) | 2.26576107 |
| 161 | glomerular basement membrane development (GO:0032836) | 2.25991425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27252483 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.93342327 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.84212538 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.71899494 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.64312965 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.60420379 |
| 7 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.60271293 |
| 8 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.40709335 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32916995 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.19323324 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06667144 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95606569 |
| 13 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.93813798 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.93813798 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92619603 |
| 16 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91126235 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.90923084 |
| 18 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.90494160 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.89741463 |
| 20 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.89624020 |
| 21 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.87679803 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.87678762 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83472219 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81581284 |
| 25 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80170544 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.79108142 |
| 27 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.78372672 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.74980758 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.73267552 |
| 30 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71125679 |
| 31 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.70922145 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.68490692 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67517118 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67264756 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66643344 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65649766 |
| 37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.63853911 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63680183 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.63237728 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62945819 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.62577576 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61765093 |
| 43 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61416531 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.60748815 |
| 45 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58595035 |
| 46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.58228610 |
| 47 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56515564 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.56371763 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.56155863 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55540896 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54745575 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51833852 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50709726 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48540098 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47863320 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.47694223 |
| 57 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47335120 |
| 58 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47246454 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42330000 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41684799 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41381494 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40030200 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.39222015 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39019891 |
| 65 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.37832909 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37779484 |
| 67 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37657333 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.36087315 |
| 69 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34906748 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34227507 |
| 71 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.33856987 |
| 72 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30778005 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30231226 |
| 74 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.28014269 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27029560 |
| 76 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24892633 |
| 77 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24892633 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24320545 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22641653 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22641653 |
| 81 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22560984 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22481031 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20196016 |
| 84 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20132314 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19543569 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18740958 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18405213 |
| 88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.17744468 |
| 89 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16958261 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16840830 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16810699 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16008749 |
| 93 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.13643995 |
| 94 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12768366 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11664749 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11470142 |
| 97 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11387701 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11165891 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10970603 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10967174 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10934805 |
| 102 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10634233 |
| 103 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09970889 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08794388 |
| 105 | * AR_19668381_ChIP-Seq_PC3_Human | 1.08403804 |
| 106 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08240328 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07825869 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07605983 |
| 109 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06953291 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05942404 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05942404 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05507829 |
| 113 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05398528 |
| 114 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.05301248 |
| 115 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05221102 |
| 116 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04665358 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04083437 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03765523 |
| 119 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03452418 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03107994 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02444255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 3.98534150 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.10089045 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.01426780 |
| 4 | MP0000751_myopathy | 3.01397990 |
| 5 | MP0005171_absent_coat_pigmentation | 2.99349936 |
| 6 | MP0000749_muscle_degeneration | 2.78231104 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 2.72116930 |
| 8 | MP0003646_muscle_fatigue | 2.67477807 |
| 9 | * MP0004084_abnormal_cardiac_muscle | 2.53814278 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.31700992 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.30810824 |
| 12 | MP0009250_abnormal_appendicular_skeleto | 2.29623072 |
| 13 | * MP0004036_abnormal_muscle_relaxation | 2.07500477 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.03623531 |
| 15 | MP0009384_cardiac_valve_regurgitation | 2.02112485 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.00378245 |
| 17 | MP0005275_abnormal_skin_tensile | 1.97391550 |
| 18 | MP0004130_abnormal_muscle_cell | 1.96904572 |
| 19 | MP0003122_maternal_imprinting | 1.95296018 |
| 20 | MP0001299_abnormal_eye_distance/ | 1.92470812 |
| 21 | MP0003279_aneurysm | 1.92097578 |
| 22 | MP0004215_abnormal_myocardial_fiber | 1.90916773 |
| 23 | MP0002282_abnormal_trachea_morphology | 1.84613481 |
| 24 | MP0004484_altered_response_of | 1.82454177 |
| 25 | MP0004134_abnormal_chest_morphology | 1.78287352 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.77470622 |
| 27 | MP0004272_abnormal_basement_membrane | 1.71961034 |
| 28 | MP0003385_abnormal_body_wall | 1.69930321 |
| 29 | MP0002108_abnormal_muscle_morphology | 1.68864177 |
| 30 | MP0004233_abnormal_muscle_weight | 1.67083769 |
| 31 | * MP0005620_abnormal_muscle_contractility | 1.63491759 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.60478781 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.60325203 |
| 34 | MP0006138_congestive_heart_failure | 1.60223944 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.55164118 |
| 36 | * MP0002972_abnormal_cardiac_muscle | 1.55049314 |
| 37 | MP0005508_abnormal_skeleton_morphology | 1.49213708 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.47814103 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.43881980 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.43249630 |
| 41 | MP0005369_muscle_phenotype | 1.41476692 |
| 42 | MP0000747_muscle_weakness | 1.39987804 |
| 43 | MP0000733_abnormal_muscle_development | 1.38424160 |
| 44 | MP0000534_abnormal_ureter_morphology | 1.37400863 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.36468029 |
| 46 | MP0003123_paternal_imprinting | 1.36127425 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.36018436 |
| 48 | MP0000163_abnormal_cartilage_morphology | 1.35294583 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.34380146 |
| 50 | MP0001661_extended_life_span | 1.32173022 |
| 51 | MP0000759_abnormal_skeletal_muscle | 1.31221274 |
| 52 | MP0003121_genomic_imprinting | 1.30524191 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.29905868 |
| 54 | MP0000762_abnormal_tongue_morphology | 1.27895001 |
| 55 | MP0003942_abnormal_urinary_system | 1.27723727 |
| 56 | MP0002115_abnormal_skeleton_extremities | 1.27656564 |
| 57 | MP0001958_emphysema | 1.27524666 |
| 58 | MP0004085_abnormal_heartbeat | 1.25060504 |
| 59 | MP0005330_cardiomyopathy | 1.21495882 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.19741343 |
| 61 | MP0002109_abnormal_limb_morphology | 1.19652508 |
| 62 | MP0005408_hypopigmentation | 1.19409547 |
| 63 | MP0002933_joint_inflammation | 1.18952696 |
| 64 | MP0001270_distended_abdomen | 1.18926920 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 1.18298216 |
| 66 | MP0002736_abnormal_nociception_after | 1.17859323 |
| 67 | MP0004270_analgesia | 1.16838718 |
| 68 | MP0010630_abnormal_cardiac_muscle | 1.15417442 |
| 69 | MP0002896_abnormal_bone_mineralization | 1.13256767 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.13242878 |
| 71 | MP0003828_pulmonary_edema | 1.12505079 |
| 72 | MP0002269_muscular_atrophy | 1.12470485 |
| 73 | MP0003755_abnormal_palate_morphology | 1.12364610 |
| 74 | MP0006054_spinal_hemorrhage | 1.11522497 |
| 75 | MP0008004_abnormal_stomach_pH | 1.08810701 |
| 76 | MP0003091_abnormal_cell_migration | 1.08258564 |
| 77 | MP0002113_abnormal_skeleton_development | 1.07246003 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.06632236 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 1.06014489 |
| 80 | MP0003937_abnormal_limbs/digits/tail_de | 1.05714380 |
| 81 | MP0010368_abnormal_lymphatic_system | 1.05427366 |
| 82 | MP0006276_abnormal_autonomic_nervous | 1.05357662 |
| 83 | MP0000049_abnormal_middle_ear | 1.02264582 |
| 84 | * MP0005385_cardiovascular_system_phenoty | 1.01203396 |
| 85 | * MP0001544_abnormal_cardiovascular_syste | 1.01203396 |
| 86 | MP0003935_abnormal_craniofacial_develop | 0.99089585 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 0.97247513 |
| 88 | MP0004510_myositis | 0.95807918 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.95082421 |
| 90 | MP0003787_abnormal_imprinting | 0.92874513 |
| 91 | MP0002932_abnormal_joint_morphology | 0.92800129 |
| 92 | MP0002249_abnormal_larynx_morphology | 0.92435010 |
| 93 | MP0002114_abnormal_axial_skeleton | 0.91539001 |
| 94 | * MP0005595_abnormal_vascular_smooth | 0.91052752 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.90868189 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.90435119 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.90210512 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.88343717 |
| 99 | * MP0000230_abnormal_systemic_arterial | 0.88209764 |
| 100 | MP0001542_abnormal_bone_strength | 0.87396401 |
| 101 | MP0002116_abnormal_craniofacial_bone | 0.86812094 |
| 102 | MP0003045_fibrosis | 0.84154659 |
| 103 | MP0002128_abnormal_blood_circulation | 0.83309899 |
| 104 | MP0002938_white_spotting | 0.82971009 |
| 105 | MP0002089_abnormal_postnatal_growth/wei | 0.82226182 |
| 106 | MP0002734_abnormal_mechanical_nocicepti | 0.82205776 |
| 107 | MP0005023_abnormal_wound_healing | 0.81295525 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.80350007 |
| 109 | MP0000432_abnormal_head_morphology | 0.78561714 |
| 110 | MP0003941_abnormal_skin_development | 0.78246730 |
| 111 | MP0002184_abnormal_innervation | 0.77605476 |
| 112 | MP0000266_abnormal_heart_morphology | 0.76387680 |
| 113 | MP0000371_diluted_coat_color | 0.74340624 |
| 114 | MP0000462_abnormal_digestive_system | 0.73548454 |
| 115 | MP0002233_abnormal_nose_morphology | 0.72818738 |
| 116 | MP0003879_abnormal_hair_cell | 0.71566380 |
| 117 | MP0005187_abnormal_penis_morphology | 0.69984221 |
| 118 | MP0000428_abnormal_craniofacial_morphol | 0.62557622 |
| 119 | MP0005670_abnormal_white_adipose | 0.59978758 |
| 120 | MP0001849_ear_inflammation | 0.56984592 |
| 121 | MP0001614_abnormal_blood_vessel | 0.53076438 |
| 122 | MP0005266_abnormal_metabolism | 0.52040604 |
| 123 | MP0005165_increased_susceptibility_to | 0.51734298 |
| 124 | MP0002102_abnormal_ear_morphology | 0.48200569 |
| 125 | MP0002925_abnormal_cardiovascular_devel | 0.47818420 |
| 126 | MP0005388_respiratory_system_phenotype | 0.47568958 |
| 127 | MP0002133_abnormal_respiratory_system | 0.47568958 |
| 128 | MP0002160_abnormal_reproductive_system | 0.45815293 |
| 129 | MP0002971_abnormal_brown_adipose | 0.45807539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 4.95849500 |
| 2 | Hypoplastic ischia (HP:0003175) | 4.94562979 |
| 3 | Abnormality of the ischium (HP:0003174) | 4.47557730 |
| 4 | Irregular epiphyses (HP:0010582) | 4.41057469 |
| 5 | Vitreoretinal degeneration (HP:0000655) | 4.18712084 |
| 6 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.05632103 |
| 7 | Calcaneovalgus deformity (HP:0001848) | 3.94687641 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.86270289 |
| 9 | Neck muscle weakness (HP:0000467) | 3.84539067 |
| 10 | Cupped ribs (HP:0000887) | 3.76889691 |
| 11 | Rimmed vacuoles (HP:0003805) | 3.61004753 |
| 12 | Deformed tarsal bones (HP:0008119) | 3.53283975 |
| 13 | Limited hip movement (HP:0008800) | 3.53219042 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.43703203 |
| 15 | Myopathic facies (HP:0002058) | 3.37972102 |
| 16 | Small epiphyses (HP:0010585) | 3.27049745 |
| 17 | Neonatal short-limb short stature (HP:0008921) | 3.19467187 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.16676572 |
| 19 | Subaortic stenosis (HP:0001682) | 3.16676572 |
| 20 | Hip contracture (HP:0003273) | 3.16143373 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.07901358 |
| 22 | Bundle branch block (HP:0011710) | 3.07391944 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 3.04876709 |
| 24 | Myoglobinuria (HP:0002913) | 3.01524041 |
| 25 | Flat capital femoral epiphysis (HP:0003370) | 2.99755481 |
| 26 | Metaphyseal dysplasia (HP:0100255) | 2.97233246 |
| 27 | Slender build (HP:0001533) | 2.95969609 |
| 28 | Abnormal finger flexion creases (HP:0006143) | 2.95449284 |
| 29 | Areflexia of lower limbs (HP:0002522) | 2.92916203 |
| 30 | Mild short stature (HP:0003502) | 2.91757038 |
| 31 | Premature rupture of membranes (HP:0001788) | 2.87891979 |
| 32 | Difficulty running (HP:0009046) | 2.86355839 |
| 33 | Aortic dissection (HP:0002647) | 2.71361092 |
| 34 | Myotonia (HP:0002486) | 2.70909962 |
| 35 | Osteoarthritis (HP:0002758) | 2.68628678 |
| 36 | Distal arthrogryposis (HP:0005684) | 2.68615403 |
| 37 | Rhabdomyolysis (HP:0003201) | 2.65959836 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.65878213 |
| 39 | Asymmetry of the thorax (HP:0001555) | 2.65503036 |
| 40 | Abnormality of femoral epiphyses (HP:0006499) | 2.64263989 |
| 41 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.64263989 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 2.61883664 |
| 43 | * Aortic aneurysm (HP:0004942) | 2.59266596 |
| 44 | Exercise-induced muscle cramps (HP:0003710) | 2.59119006 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.58353122 |
| 46 | Vascular tortuosity (HP:0004948) | 2.55639329 |
| 47 | Sudden death (HP:0001699) | 2.55402479 |
| 48 | Abnormality of the pubic bones (HP:0003172) | 2.55370789 |
| 49 | Metaphyseal cupping (HP:0003021) | 2.53514813 |
| 50 | Malignant hyperthermia (HP:0002047) | 2.52905595 |
| 51 | Delayed epiphyseal ossification (HP:0002663) | 2.52227321 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.52031599 |
| 53 | Exercise-induced myalgia (HP:0003738) | 2.49288085 |
| 54 | Flat acetabular roof (HP:0003180) | 2.47260957 |
| 55 | Muscle stiffness (HP:0003552) | 2.46808681 |
| 56 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.46094572 |
| 57 | Atrial fibrillation (HP:0005110) | 2.45519426 |
| 58 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.41860768 |
| 59 | Mesomelia (HP:0003027) | 2.40109419 |
| 60 | Broad ribs (HP:0000885) | 2.39729012 |
| 61 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.39480788 |
| 62 | Dilated cardiomyopathy (HP:0001644) | 2.38408719 |
| 63 | Frequent falls (HP:0002359) | 2.38231645 |
| 64 | Abnormal tarsal ossification (HP:0008369) | 2.37979228 |
| 65 | Gowers sign (HP:0003391) | 2.37134461 |
| 66 | Generalized muscle weakness (HP:0003324) | 2.36458592 |
| 67 | Arterial tortuosity (HP:0005116) | 2.36422763 |
| 68 | Ventricular tachycardia (HP:0004756) | 2.36355911 |
| 69 | Muscle fiber inclusion bodies (HP:0100299) | 2.34483995 |
| 70 | Muscular dystrophy (HP:0003560) | 2.29150030 |
| 71 | Primary atrial arrhythmia (HP:0001692) | 2.28168469 |
| 72 | Waddling gait (HP:0002515) | 2.25143174 |
| 73 | Abnormal foot bone ossification (HP:0010675) | 2.24562264 |
| 74 | Absent frontal sinuses (HP:0002688) | 2.21860343 |
| 75 | Popliteal pterygium (HP:0009756) | 2.20811267 |
| 76 | Coxa vara (HP:0002812) | 2.20515537 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.18870718 |
| 78 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.17842193 |
| 79 | Abnormality of the femoral head (HP:0003368) | 2.16772799 |
| 80 | Fibular aplasia (HP:0002990) | 2.15667457 |
| 81 | Abnormality of the calcaneus (HP:0008364) | 2.14518633 |
| 82 | Nemaline bodies (HP:0003798) | 2.13693726 |
| 83 | Supraventricular tachycardia (HP:0004755) | 2.11966068 |
| 84 | Lumbar hyperlordosis (HP:0002938) | 2.11656522 |
| 85 | EMG: neuropathic changes (HP:0003445) | 2.11639888 |
| 86 | Ulnar deviation of the wrist (HP:0003049) | 2.11151326 |
| 87 | Supraventricular arrhythmia (HP:0005115) | 2.10074080 |
| 88 | Weak cry (HP:0001612) | 2.09379308 |
| 89 | Exostoses (HP:0100777) | 2.06785818 |
| 90 | Spondylolisthesis (HP:0003302) | 2.05528482 |
| 91 | Cervical subluxation (HP:0003308) | 2.05178397 |
| 92 | Abnormality of the vertebral endplates (HP:0005106) | 2.05108795 |
| 93 | Abnormality of dentin (HP:0010299) | 2.03948808 |
| 94 | Genu varum (HP:0002970) | 2.03736769 |
| 95 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.03512527 |
| 96 | Increased connective tissue (HP:0009025) | 2.00758080 |
| 97 | Ovoid vertebral bodies (HP:0003300) | 2.00450809 |
| 98 | Fatigable weakness (HP:0003473) | 2.00019812 |
| 99 | Abnormality of the neuromuscular junction (HP:0003398) | 2.00019812 |
| 100 | Spinal rigidity (HP:0003306) | 1.99784547 |
| 101 | Limb-girdle muscle atrophy (HP:0003797) | 1.98017286 |
| 102 | Scapular winging (HP:0003691) | 1.97680685 |
| 103 | EMG: myopathic abnormalities (HP:0003458) | 1.97357030 |
| 104 | Proximal amyotrophy (HP:0007126) | 1.96921220 |
| 105 | Short femoral neck (HP:0100864) | 1.96511458 |
| 106 | Mitral valve prolapse (HP:0001634) | 1.96268759 |
| 107 | Limb-girdle muscle weakness (HP:0003325) | 1.95313868 |
| 108 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.94814765 |
| 109 | Broad long bones (HP:0005622) | 1.93788568 |
| 110 | Ankle contracture (HP:0006466) | 1.93616400 |
| 111 | Flattened epiphyses (HP:0003071) | 1.93390221 |
| 112 | Knee flexion contracture (HP:0006380) | 1.93132872 |
| 113 | Irregular vertebral endplates (HP:0003301) | 1.92651938 |
| 114 | Lipoatrophy (HP:0100578) | 1.90767055 |
| 115 | Bulbar palsy (HP:0001283) | 1.89881265 |
| 116 | Bell-shaped thorax (HP:0001591) | 1.89814357 |
| 117 | Abnormality of incisor morphology (HP:0011063) | 1.89654806 |
| 118 | Limited elbow extension (HP:0001377) | 1.89517829 |
| 119 | Broad phalanx (HP:0006009) | 1.89269751 |
| 120 | Breech presentation (HP:0001623) | 1.87882680 |
| 121 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.87698193 |
| 122 | Absent epiphyses (HP:0010577) | 1.87698193 |
| 123 | Bladder diverticulum (HP:0000015) | 1.87174152 |
| 124 | Broad metatarsal (HP:0001783) | 1.86507567 |
| 125 | Hepatoblastoma (HP:0002884) | 1.85761558 |
| 126 | Increased variability in muscle fiber diameter (HP:0003557) | 1.83423087 |
| 127 | Distal lower limb muscle weakness (HP:0009053) | 1.81595609 |
| 128 | Round ear (HP:0100830) | 1.81260756 |
| 129 | Micromelia (HP:0002983) | 1.80928760 |
| 130 | Wormian bones (HP:0002645) | 1.80846418 |
| 131 | Steppage gait (HP:0003376) | 1.80805847 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80592004 |
| 133 | Blue irides (HP:0000635) | 1.80327064 |
| 134 | Type 2 muscle fiber atrophy (HP:0003554) | 1.80020414 |
| 135 | Heart block (HP:0012722) | 1.79980562 |
| 136 | Platyspondyly (HP:0000926) | 1.79544986 |
| 137 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79408399 |
| 138 | Absent phalangeal crease (HP:0006109) | 1.77670723 |
| 139 | Spinal cord compression (HP:0002176) | 1.76628571 |
| 140 | Distal lower limb amyotrophy (HP:0008944) | 1.76392994 |
| 141 | Abnormal vertebral ossification (HP:0100569) | 1.74454563 |
| 142 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.72918333 |
| 143 | Abnormal atrioventricular conduction (HP:0005150) | 1.72614727 |
| 144 | Soft skin (HP:0000977) | 1.72604206 |
| 145 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72362825 |
| 146 | Overgrowth (HP:0001548) | 1.71697210 |
| 147 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.71664667 |
| 148 | Fibular hypoplasia (HP:0003038) | 1.70651646 |
| 149 | Facial diplegia (HP:0001349) | 1.68702443 |
| 150 | Metatarsus adductus (HP:0001840) | 1.68386894 |
| 151 | Hyperkalemia (HP:0002153) | 1.66813717 |
| 152 | Ulnar deviation of finger (HP:0009465) | 1.62369199 |
| 153 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.61709666 |
| 154 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.61709666 |
| 155 | Aplasia of the musculature (HP:0100854) | 1.60602766 |
| 156 | Delayed gross motor development (HP:0002194) | 1.58409002 |
| 157 | Lower limb amyotrophy (HP:0007210) | 1.58253453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.88951833 |
| 2 | PINK1 | 3.95278797 |
| 3 | LATS1 | 3.67901499 |
| 4 | STK24 | 3.09154044 |
| 5 | DDR2 | 3.08133117 |
| 6 | STK38L | 3.05541536 |
| 7 | EPHA3 | 2.81948612 |
| 8 | PIK3CA | 2.78006743 |
| 9 | LATS2 | 2.23740932 |
| 10 | TTN | 2.11326000 |
| 11 | DMPK | 2.03379305 |
| 12 | MYLK | 2.00360059 |
| 13 | STK3 | 1.78274573 |
| 14 | NTRK3 | 1.66775825 |
| 15 | KSR1 | 1.62880195 |
| 16 | ZAK | 1.56029783 |
| 17 | PLK2 | 1.55658717 |
| 18 | MST1R | 1.53054375 |
| 19 | PRKD3 | 1.52405304 |
| 20 | MAP3K4 | 1.47312471 |
| 21 | NUAK1 | 1.43427097 |
| 22 | PTK2B | 1.43392540 |
| 23 | PKN2 | 1.42406374 |
| 24 | MINK1 | 1.37223813 |
| 25 | MUSK | 1.35000449 |
| 26 | SIK3 | 1.29961710 |
| 27 | CDC42BPA | 1.19079794 |
| 28 | PHKG2 | 1.13511154 |
| 29 | PHKG1 | 1.13511154 |
| 30 | STK38 | 1.11821407 |
| 31 | NTRK1 | 1.10992584 |
| 32 | GRK5 | 1.08353289 |
| 33 | PBK | 1.06869079 |
| 34 | CDK8 | 1.05560393 |
| 35 | EPHB2 | 1.05432484 |
| 36 | TNIK | 1.04724523 |
| 37 | PAK3 | 1.03977744 |
| 38 | SGK3 | 1.03688352 |
| 39 | ROCK1 | 1.03550526 |
| 40 | LMTK2 | 1.03410764 |
| 41 | SGK2 | 1.03006459 |
| 42 | MELK | 0.99722553 |
| 43 | FER | 0.99367335 |
| 44 | SIK1 | 0.99176827 |
| 45 | TRPM7 | 0.99119584 |
| 46 | PDGFRA | 0.96932951 |
| 47 | TAF1 | 0.94421577 |
| 48 | KSR2 | 0.94289867 |
| 49 | PIK3CG | 0.94005129 |
| 50 | RET | 0.93023951 |
| 51 | CAMK2G | 0.91932379 |
| 52 | MAP2K4 | 0.89190463 |
| 53 | WNK1 | 0.85557011 |
| 54 | MAPK13 | 0.84290234 |
| 55 | MET | 0.84103751 |
| 56 | MAP2K7 | 0.83334850 |
| 57 | MAP3K10 | 0.82078068 |
| 58 | TIE1 | 0.80962786 |
| 59 | PAK6 | 0.80253396 |
| 60 | FGFR3 | 0.77957730 |
| 61 | FRK | 0.76423509 |
| 62 | MAPK7 | 0.74926931 |
| 63 | NEK9 | 0.74639830 |
| 64 | MAPKAPK3 | 0.73221486 |
| 65 | MAP3K7 | 0.72198484 |
| 66 | TAOK1 | 0.72190848 |
| 67 | MAP3K9 | 0.71705405 |
| 68 | FGFR1 | 0.68549618 |
| 69 | NEK6 | 0.68258598 |
| 70 | ERBB3 | 0.66627678 |
| 71 | MARK3 | 0.65857432 |
| 72 | MAPKAPK5 | 0.64695079 |
| 73 | EEF2K | 0.63582697 |
| 74 | MAP3K6 | 0.62368718 |
| 75 | SGK494 | 0.61780120 |
| 76 | SGK223 | 0.61780120 |
| 77 | NEK1 | 0.61464353 |
| 78 | MOS | 0.60853671 |
| 79 | CDK9 | 0.60569199 |
| 80 | RIPK1 | 0.59877831 |
| 81 | RAF1 | 0.59313763 |
| 82 | NLK | 0.58472428 |
| 83 | CAMK2B | 0.56539881 |
| 84 | VRK1 | 0.55720550 |
| 85 | CAMK2A | 0.54100229 |
| 86 | MARK1 | 0.53715531 |
| 87 | PNCK | 0.53649287 |
| 88 | EPHA4 | 0.53319148 |
| 89 | TRIB3 | 0.52876204 |
| 90 | MAPK12 | 0.52785698 |
| 91 | PAK2 | 0.52053185 |
| 92 | DAPK3 | 0.51924993 |
| 93 | PKN1 | 0.50958180 |
| 94 | BCR | 0.50533623 |
| 95 | PDK4 | 0.50529289 |
| 96 | PDK3 | 0.50529289 |
| 97 | MAPK4 | 0.49585977 |
| 98 | PRKCE | 0.48397632 |
| 99 | AKT2 | 0.48172103 |
| 100 | WNK4 | 0.48020028 |
| 101 | PTK2 | 0.47998229 |
| 102 | CASK | 0.47081864 |
| 103 | AKT3 | 0.45779572 |
| 104 | CAMKK2 | 0.45718049 |
| 105 | STK39 | 0.45298918 |
| 106 | MAP3K3 | 0.44799547 |
| 107 | CSNK1G1 | 0.44604454 |
| 108 | CAMK2D | 0.44386718 |
| 109 | PDGFRB | 0.44154048 |
| 110 | ILK | 0.42968818 |
| 111 | * PRKG1 | 0.42524057 |
| 112 | PDK1 | 0.42300690 |
| 113 | PRKAA1 | 0.41595298 |
| 114 | ARAF | 0.40808925 |
| 115 | CCNB1 | 0.40063128 |
| 116 | TGFBR1 | 0.39461412 |
| 117 | LIMK1 | 0.38802028 |
| 118 | MAP2K1 | 0.38793913 |
| 119 | IGF1R | 0.38688501 |
| 120 | PRKACA | 0.38049594 |
| 121 | PRKAA2 | 0.37121485 |
| 122 | SGK1 | 0.36862117 |
| 123 | CSNK1G2 | 0.36638289 |
| 124 | HIPK2 | 0.36018952 |
| 125 | ADRBK1 | 0.35967568 |
| 126 | MAP3K5 | 0.35326798 |
| 127 | PAK1 | 0.34824604 |
| 128 | ICK | 0.33767751 |
| 129 | CAMK1 | 0.33550161 |
| 130 | BMX | 0.31723461 |
| 131 | TGFBR2 | 0.31572428 |
| 132 | BMPR1B | 0.31372782 |
| 133 | CAMK4 | 0.29488611 |
| 134 | STK11 | 0.29322307 |
| 135 | RPS6KA3 | 0.29176853 |
| 136 | CSNK1G3 | 0.28672956 |
| 137 | PRKACB | 0.28248335 |
| 138 | PRKD1 | 0.27914497 |
| 139 | NEK2 | 0.27358153 |
| 140 | BRSK2 | 0.27183567 |
| 141 | PRKACG | 0.24458210 |
| 142 | ROCK2 | 0.24448444 |
| 143 | PLK4 | 0.21971628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.79052040 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.75115187 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.73437949 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.62098569 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.07923724 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.03721419 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.01706732 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.84805413 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77118129 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.71233816 |
| 11 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.66812546 |
| 12 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.64873208 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61405354 |
| 14 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.54938947 |
| 15 | Melanogenesis_Homo sapiens_hsa04916 | 1.54360235 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48382810 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40068705 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.37897586 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37555367 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35740196 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33839524 |
| 22 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.32574301 |
| 23 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.28197740 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.25468373 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.24486697 |
| 26 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.22787229 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.21800527 |
| 28 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.20692363 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20679383 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.20674977 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20599665 |
| 32 | * Olfactory transduction_Homo sapiens_hsa04740 | 1.16794484 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15509237 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.13987876 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13787402 |
| 36 | * Salivary secretion_Homo sapiens_hsa04970 | 1.13747081 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13718495 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13242396 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.13174283 |
| 40 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.12852486 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12537715 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10196977 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.08193147 |
| 44 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.05408975 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05368267 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04375051 |
| 47 | * Long-term depression_Homo sapiens_hsa04730 | 1.03929659 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03674220 |
| 49 | Taste transduction_Homo sapiens_hsa04742 | 1.01247558 |
| 50 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.00741092 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99901246 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99265355 |
| 53 | Melanoma_Homo sapiens_hsa05218 | 0.98784151 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98123914 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97088018 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96165256 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95461481 |
| 58 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95323229 |
| 59 | * Platelet activation_Homo sapiens_hsa04611 | 0.94992394 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94204284 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93586836 |
| 62 | * Gap junction_Homo sapiens_hsa04540 | 0.91482405 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90952065 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90204473 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89678991 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89275743 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88180500 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87563947 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.87008523 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84984718 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84877044 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84698564 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83006587 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82453131 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82122176 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.80018287 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79603476 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79263636 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79188704 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78906676 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78835953 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78827918 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.78331155 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77430225 |
| 85 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77022274 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.76744039 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75613370 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75598263 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75521841 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.75513795 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.75312591 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74858808 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74832310 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72315165 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72079364 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71772166 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71626531 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.71564489 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70353967 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68827767 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68676012 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68222722 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68132989 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66597102 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66182187 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65091872 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62992549 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.62729700 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61832560 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60638416 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60489731 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58862066 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58241176 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56434982 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53481246 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52941054 |
| 117 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52673696 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52191252 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44352510 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44187471 |
| 121 | Bile secretion_Homo sapiens_hsa04976 | 0.41239084 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40685125 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38233227 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.32572892 |

